Compounds > garenoxacin
Page last updated: 2024-09-03

garenoxacin and clinafloxacin

garenoxacin has been researched along with clinafloxacin in 4 studies

Compound Research Comparison

Studies
(garenoxacin)		Trials
(garenoxacin)		Recent Studies (post-2010)
(garenoxacin)		Studies
(clinafloxacin)		Trials
(clinafloxacin)		Recent Studies (post-2010) (clinafloxacin)
19519461831619

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aubry, A; Cambau, E; Jarlier, V; Matrat, S; Petrella, S; Sougakoff, W1
Blaskovich, MAT; Pham, TDM; Ziora, ZM1
Finegold, S; Goldstein, E; Gorbach, SL; Harrell, L; Hecht, DW; Jacobus, NV; Jenkins, S; McDermott, LA; Pierson, C; Rihs, J; Ruthazer, R; Snydman, DR; Venezia, R1
Piddock, L; Ricci, V1

Reviews

1 review(s) available for garenoxacin and clinafloxacin

ArticleYear
Quinolone antibiotics.
    MedChemComm, 2019, Oct-01, Volume: 10, Issue:10

    Topics:

2019

Other Studies

3 other study(ies) available for garenoxacin and clinafloxacin

ArticleYear
Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5

    Topics: Anti-Infective Agents; DNA; DNA Gyrase; DNA, Superhelical; Enzyme Inhibitors; Mycobacterium leprae; Quinolones; Topoisomerase II Inhibitors

2007
In vitro activities of newer quinolones against bacteroides group organisms.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:10

    Topics: Anti-Infective Agents; Aza Compounds; Bacteroides; Bacteroides fragilis; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Indoles; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Quinolines; Quinolones

2002
Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:4

    Topics: Aza Compounds; Bacteroides fragilis; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Membrane Transport Modulators; Membrane Transport Proteins; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines

2003